Sonig Alok
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Sonig Alok. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BAX | EVP,Group President,Pharma | Tax Withholding | 3,191 | $24.17 | $77,126 | Sep 2, 2025 |
| BAX | EVP,Group President,Pharma | Award / Grant | 29,966 | — | — | Mar 6, 2025 |
| BAX | EVP,Group President,Pharma | Tax Withholding | 1,936 | $34.86 | $67,489 | Mar 3, 2025 |
| BAX | EVP,Group President, Pharma | Tax Withholding | 3,054 | $37.85 | $115,594 | Sep 3, 2024 |
| BAX | EVP,Group President, Pharma | Award / Grant | 83,353 | — | — | Mar 6, 2024 |
| BAX | EVP, Group President, Pharma | Tax Withholding | 1,832 | $41.01 | $75,130 | Mar 1, 2024 |
| BAX | EVP, Group President, Pharm | Tax Withholding | 2,059 | $40.60 | $83,595 | Sep 1, 2023 |
| BAX | EVP, Group President, Pharm | Award / Grant | 15,428 | — | — | Mar 1, 2023 |